Listar Grupo de Polímeros por autor "Roselló-Lletí, Esther"
Mostrando ítems 1-1 de 1
-
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Aragón Herrera, Alana; Otero-Santiago, Manuel; Anido Varela, Laura; Moraña Fernández, Sandra; Campos-Toimil, Manuel; García-Caballero, Tomas; Barral, Luis; Tarazón, Estefanía; Roselló-Lletí, Esther; Portolés, M; Gualillo, Oreste; Moscoso, Isabel; Lage Fernández, Ricardo; González-Juanatey, J.R.; Feijóo-Bandín, Sandra; Lago, Francisca (Frontiers Media, 2022-01-02)[Abstract] The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial evidenced the potential of sodium-glucose cotransporter 2 (SGLT2) inhibitors for ...